Origin Therapeutics Sponsoring Microdose Psychedelic Capital Conference
Vancouver, British Columbia, March 23, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelic-focused…